Trasylol Heart Surgery
Trasylol Heart Surgery Lawyers
Trasylol heart surgery side effects have recently been associated with an increased risk of stroke, heart attack and kidney failure in coronary bypass surgery patients.
Fourteen years ago the Federal Drug Administration (FDA) approved Aprotinin which is manufactured by Bayer and marketed under the brand name Trasylol. Heart surgery, stroke and kidney failure risks are increasingly being reported according to recent Trasylol studies. Bayer’s Trasylol sales are reported to have accelerated over the past several years with $600 million projected for 2006.
Trasylol Linked to Heart Attacks and Kidney Failure
A 2006 study published in the New England Journal of Medicine (NEJM) reported an increased risk of developing Trasylol stroke, kidney failure and heart failure in open heart surgery patients.
The majority of Trasylol heart surgery patients are not aware that their surgeon administered Trasylol during their bypass surgery. Future cardiac surgery patients are advised to discuss Trasylol use with their treating physician to avoid the increased risk of stroke, kidney failure and heart attack. Trasylol lawyers are able to help find out if you were given Trasylol during your surgery and if you have suffered side effects associated with the drug.
Trasylol Lawyer Open Heart Surgery
Trasylol works to limit bleeding during heart surgery. Approximately one million patients worldwide undergo heart surgery after suffering a heart attack. Excessive bleeding is one of the most serious complications for heart surgery patients. The majority of these patients are given one of three drugs that affect the way in which blood clots. Clotting medications such as Trasylol reduce the amount of blood transfusion required by bypass surgery patients.
Trasylol Heart Surgery Alternative Drugs Available
The NEJM study reported that 2 other generic medications are available that are safer and less expensive than Trasylol.
• Trasylol cost per dose is $1,300
• The generic aminocaproic acid cost per dose is $11
• The generic tranexamic acid cost per dose is $44
The generic drugs were shown to be far less costly with no increased risk of heart attack, stroke or kidney failure.
Trasylol Heart Surgery Warnings
On September 21, 2006 the Federal Drug Administration’s Cardiovascular and Renal Drug Advisory Committee met to review the most recent data regarding the dangers of the Trasylol heart surgery drug. Following the meeting the FDA learned that Bayer did not disclose a previous Trasylol study that it had conducted involving 67,000 heart surgery patients. On September 29, 2006 the FDA issued a public health advisory regarding this previously undisclosed Trasylol study. Preliminary review of this Trasylol study suggested that Trasylol was associated with risk for kidney failure, stroke and congestive heart failure.
If you or a loved one have had open heart surgery and subsequently suffered Trasylol stroke, kidney failure or heart failure you may be able to file a Trasylol lawsuit. A Trasylol lawyer can help you evaluate your claim.